Project Grant R21OH013145

The Centers for Disease Control and Prevention's National Institute for Occupational Safety and Health awarded Icahn School of Medicine at Mount Sinai $249,871 on September 1, 2026, to improve World Trade Center responder mental health through precision treatment of comorbid insomnia and sleep apnea under CDC Investigations and Technical Assistance (CFDA 93.283). The project runs through August 31, 2028, with performance in New York, New York. The award funds research and clinical intervention...

<p>The National Institute for Occupational Safety and Health awarded Sloan-Kettering Institute for Cancer Research $287,197 on September 1, 2026, under CDC Investigations and Technical Assistance (CFDA 93.283) to conduct genomic characterization and clinical outcomes research of cancers in World Trade Center-exposed survivors and responders. Work is performed in New York, New York, with a period of performance through August 31, 2028.</p>

The Centers for Disease Control and Prevention, operating under the National Institute for Occupational Safety and Health, awarded New York University $243,709 on September 1, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to support the WTC Survivors: Lifestyle Medicine Study. The project runs through August 31, 2028, with place of performance in New York, New York. The CDC Investigations and Technical Assistance program assists state and local health...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded The Trustees of Columbia University in the City of New York $237,764 under the CDC Investigations and Technical Assistance program (CFDA 93.283) on September 1, 2026, to investigate distal airway dysfunction following childhood exposure to the World Trade Center attack and to identify predictors and clinical consequences of that dysfunction. The award funds a two-year project with performance through...

The Centers for Disease Control and Prevention awarded New York University School of Medicine $246,434 on September 1, 2026, for a project grant investigating epigenetic pathways mediating exposure effects on breast cancer risk in World Trade Center survivors. The award funds research spanning September 1, 2026, through August 31, 2028, and is performed in New York. The project operates under CDC Investigations and Technical Assistance (CFDA 93.283), which supports investigations and...

The Department of Health and Human Services Centers for Disease Control and Prevention (National Institute for Occupational Safety and Health) awarded The Research Foundation For The State University of New York, operating as Stony Brook University, $247,383 on September 1, 2026, under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283) to support research on interneuronal aging in trauma-exposed World Trade Center responders. Work is...

The National Center for Advancing Translational Sciences awarded $168,000 to Icahn School of Medicine at Mount Sinai on May 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to leverage a lung organoid model to study early cystic fibrosis lung disease. The recipient will characterize cystic fibrosis transmembrane conductance regulator (CFTR) gene transcript expression and CFTR protein expression and function in three-dimensional lung organoids that...

The Centers for Disease Control and Prevention awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $230,155 on September 1, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to investigate dynamic PTSD-related cognitive risk in aging World Trade Center responders. Performance occurs in New York. The award runs through August 31, 2028. The Research Foundation For The State University Of New York functions as...

This federal Project Grant award of $202,800 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. The award is focused on &quot;Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis&quot; and will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award...

The National Institute of Environmental Health Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded $815,546 to Icahn School of Medicine at Mount Sinai on June 22, 2026, under the Environmental Health program (CFDA 93.113) to investigate how early-life chemical exposures affect executive function and brain development across adolescence. The research leverages naturally shed deciduous teeth as biomarkers to measure in utero and early childhood...